Compare funds
Evaluate funds side by side, to find the best fit for your investment goals.
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. The Index measures the performance of companies listed on the NASDAQ Stock Market that are classified as either biotechnology companies or pharmaceutical companies, according to their Industry Classification Benchmark (ICB) and that also meet other eligibility criteria as determined by NASDAQ, Inc. (the Index Provider), including minimum market capitalisation and liquidity requirements.
View fundThe investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index. The Index measures the performance of companies listed on the NASDAQ Stock Market that are classified as either biotechnology companies or pharmaceutical companies, according to their Industry Classification Benchmark (ICB) and that also meet other eligibility criteria as determined by NASDAQ, Inc. (the Index Provider), including minimum market capitalisation and liquidity requirements.
View fundKey takeaways
The ETFs track the same security, and so are effectively the same fund. £BTEK is traded in British pounds (£) on the London Stock Exchange, while $BTEC is traded in US dollars ($) on the same exchange.
Fund highlights
Fund name | iShares Nasdaq US Biotechnology | iShares Nasdaq US Biotechnology |
|---|---|---|
GBP | USD | |
USD | USD | |
| Accumulating | Accumulating | |
Fund size | £858M | $1.1B |
| 1.00 | 1.00 | |
Last price | £7.74 | $10.35 |
| 0.35% | 0.35% | |
Fund manager | BlackRock | BlackRock |
Benchmark | NASDAQ Biotechnology Index (Net Total Return) | NASDAQ Biotechnology Index (Net Total Return) |
Risk | ||
Ticker | £BTEK | $BTEC |
Primary listing | LSE | LSE |
Documents |
Market data provided by CBOE Europe and Deutsche Börse.
Performance
CumulativeRolling yearsLump sum investment
Sector exposure
ChartTable
£BTEK
$BTEC
Top holdings
Gilead Sciences
8.57%
Amgen
8.16%
Vertex Pharmaceuticals
7.56%
Moderna
6.33%
Regeneron
5.35%
Revolution Medicines
2.76%
Illumina
2.65%
Biogen
2.35%
Alnylam Pharmaceuticals
2.03%
Other
54.24%
Gilead Sciences
8.57%
Amgen
8.16%
Vertex Pharmaceuticals
7.56%
Moderna
6.33%
Regeneron
5.35%
Revolution Medicines
2.76%
Illumina
2.65%
Biogen
2.35%
Alnylam Pharmaceuticals
2.03%
Other
54.24%
Invest in £BTEK or $BTEC on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.